Clinical reference
Cholinergic agent · Acetylcholinesterase inhibitor · Neurology, Pediatrics, Internal Medicine
Pyridostigmine bromide is an acetylcholinesterase inhibitor used primarily in the symptomatic treatment of myasthenia gravis and to reverse nondepolarizing neuromuscular blockade. By inhibiting acetylcholinesterase at the neuromuscular junction, it increases available acetylcholine and enhances neuromuscular transmission. Formulations include oral syrup 6…